KLAVA Innovation

KLAVA Innovation is a pioneering startup in the healthcare sector, specifically targeting addiction treatment through advanced digital technologies. The company aims to support millions of individuals struggling with various addictions, such as alcohol, tobacco, and other substances. By leveraging evidence-based studies and cutting-edge digital tools, KLAVA Innovation seeks to reduce the high relapse rates associated with addictive disorders.

The company operates in the digital health market, focusing on developing Digital Therapeutics (DTx). Digital Therapeutics are software-based interventions that help prevent, manage, or treat medical conditions. KLAVA Innovation collaborates with renowned institutions like the Addiction Center of Paul Brousse Hospital and INRIA (the French National Institute for Research in Computer Science and Control) to enhance its offerings. One of its key innovations is a facial recognition system designed to monitor emotions and detect early signs of relapse in patients.

KLAVA Innovation primarily serves healthcare providers, addiction treatment centers, and research institutions. Its business model revolves around creating and licensing its digital solutions to these clients. The company generates revenue through subscription fees, licensing agreements, and potentially through partnerships with healthcare organizations and insurance companies.

In summary, KLAVA Innovation is at the forefront of integrating digital technology with addiction treatment, aiming to make a significant impact on public health by reducing relapse rates and improving patient outcomes.

Keywords: addiction treatment, digital health, facial recognition, relapse detection, Digital Therapeutics, healthcare innovation, evidence-based, emotional monitoring, subscription model, healthcare providers.